Subject: RE: Report March
From: "Sopo Belkania" <Belkania>
To: Graeme Robertson <[email-masked]>; Aysan Murtezaoglu <[email-masked]>
Date: Wed, 04 Apr 2018 18:42:08 +0300

Dear Graeme,

Yes I will be there. We are also looking forward to meet you at EASL Congress. 

Best regards,

Sopo Belkania 
Head of HR Management and International Relations Department
Ministry of Labor, Health and Social Affairs of Georgia
144 A.Tsereteli Avenue, 0159, Tbilisi, Georgia
Mobile number: +995 599 22 32 32

-----Original Message-----
From: Graeme Robertson [mailto:[email-masked]] 
Sent: Wednesday, April 4, 2018 4:47 PM
To: Sopo Belkania; Aysan Murtezaoglu
Subject: RE: Report March

Dear Sopo,

Thank you for the March report, I am very much looking forward to meeting with the Georgian delegation next week at EASL Congress. Will you be there?

Best wishes

Graeme

Graeme.A Robertson
Senior Director,  Africa & CIS
Access Operations & Emerging Markets
--------------------------------------------------------------------------------------------------------------------------------------------------
Gilead Sciences Europe Ltd . Registered as a limited company in England and Wales . Registered number 05510315 Registered office: South Building . 2 Roundwood Avenue . Stockley Park . Uxbridge . UB11 1AZ . England
Telephone: +44(0)208 587 2228 . Mobile: +44(0)7789 268 043 . Fax: +44(0)208 744 6773

-----Original Message-----
From: Sopo Belkania [mailto:[email-masked]]
Sent: 04 April 2018 13:33
To: Graeme Robertson; Aysan Murtezaoglu
Subject: Report March

Dear Graeme and Aysan,

Hope this email find you well.

Please find attached report for March month.

Best regards,

Sopo Belkania
Head of HR Management and International Relations Department Ministry of Labor, Health and Social Affairs of Georgia
144 A.Tsereteli Avenue, 0159, Tbilisi, Georgia Mobile number: +995 599 22 32 32

DISCLAIMER If you have received this message in error, please contact the sender immediately by return e-mail and notify the sender and then delete this message (including any attachments) from your system. This communication and any attachments contain information which is confidential and may also be legally privileged. It is for the exclusive use of the intended recipient(s). If you are not the intended recipient(s) please note that any form of disclosure, distribution, copying or use of this communication or the information in it or in any attachments is strictly prohibited and may be unlawful. E-mail communications cannot be guaranteed to be secure or error free, as information could be intercepted, corrupted, amended, lost, destroyed, arrive late or incomplete, or contain viruses. Gilead does not accept liability for any such matters or their consequences. Anyone who communicates with Gilead by e-mail is taken to accept the risks in doing so. Gilead has taken every reasonable precaution to ensure that any attachment to this e-mail has been swept for viruses. However, Gilead cannot accept liability for any damage sustained as a result of viruses and would advise that you carry out your own virus checks before opening any attachment. Gilead Sciences Europe Ltd ; Registered as a limited company in England and Wales ; Registered number 5510315 Registered office: South Building ; 2 Roundwood Avenue ; Stockley Park ; Uxbridge ; UB11 1AF ; England